AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 149 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $570,000 | +73.3% | 89,760 | +7.1% | 0.00% | +100.0% |
Q3 2019 | $329,000 | -31.5% | 83,790 | -15.4% | 0.00% | -33.3% |
Q2 2019 | $480,000 | +9.8% | 99,003 | +85.7% | 0.00% | 0.0% |
Q1 2019 | $437,000 | +32.0% | 53,305 | -10.9% | 0.00% | +50.0% |
Q4 2018 | $331,000 | – | 59,795 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 7,121,283 | $53,979,000 | 4.02% |
DAFNA Capital Management LLC | 853,538 | $6,470,000 | 2.70% |
Baupost Group | 17,527,968 | $132,862,000 | 1.96% |
Nantahala Capital Management | 6,559,478 | $49,721,000 | 1.86% |
Novo Holdings A/S | 3,393,039 | $25,719,000 | 1.72% |
Abrams Capital Management | 5,656,462 | $42,876,000 | 1.69% |
Stanley-Laman Group, Ltd. | 319,073 | $2,419,000 | 0.73% |
Integral Health Asset Management, LLC | 200,000 | $1,516,000 | 0.67% |
KNOTT DAVID M | 135,169 | $1,025,000 | 0.65% |
Leap Investments LP | 54,700 | $415,000 | 0.61% |